Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Acadia Healthcare Company (ACHC) Cost of Revenue (2016 - 2025)

Acadia Healthcare Company (ACHC) has disclosed Cost of Revenue for 16 consecutive years, with $176.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Cost of Revenue rose 183.78% to $176.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $553.3 million, a 1732.21% increase, with the full-year FY2025 number at $553.3 million, up 390.9% from a year prior.
  • Cost of Revenue was $176.1 million for Q4 2025 at Acadia Healthcare Company, down from $320.3 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $320.3 million in Q3 2025 to a low of -$210.2 million in Q4 2024.
  • A 5-year average of $74.3 million and a median of $75.1 million in 2021 define the central range for Cost of Revenue.
  • Peak YoY movement for Cost of Revenue: tumbled 887.81% in 2024, then surged 981.35% in 2025.
  • Acadia Healthcare Company's Cost of Revenue stood at $79.1 million in 2021, then skyrocketed by 167.54% to $211.6 million in 2022, then crashed by 87.39% to $26.7 million in 2023, then crashed by 887.81% to -$210.2 million in 2024, then soared by 183.78% to $176.1 million in 2025.
  • Per Business Quant, the three most recent readings for ACHC's Cost of Revenue are $176.1 million (Q4 2025), $320.3 million (Q3 2025), and $28.5 million (Q2 2025).